Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

Jul 06, 2020

Mylan Secures Regulatory Approval for Remdesivir Lyophilized Powder for Injection 100 mg/vial in India for Restricted Emergency Use in COVID-19 Patients

Jun 30, 2020

Mylan Shareholders Overwhelmingly Approve Proposed Combination with Upjohn

Jun 18, 2020

Mylan Wins District Court Decision Against Biogen's Tecfidera® Patent

Jun 11, 2020

Mylan and Biocon Announce U.S. FDA Approval of Semglee™ (insulin glargine injection)

Jun 04, 2020

Mylan and Lupin Receive European Marketing Authorization for Nepexto®, Biosimilar Etanercept

May 29, 2020

Mylan Invalidates Sanofi's Lantus® SoloSTAR® Device Patents in IPR Proceedings

May 13, 2020

Mylan to Present at the 2020 RBC Capital Markets' Virtual Global Healthcare Conference

May 12, 2020

Mylan to Supply Investigational Antiviral Remdesivir for the Potential Treatment of COVID-19

May 11, 2020

Mylan Reports First Quarter 2020 Results and Reaffirms 2020 Guidance

May 08, 2020

Mylan to Present at the BofA Securities Virtual Health Care Conference 2020

Pagination

First page
Previous page
Page 1
Page 2
Current page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2023 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.